Dawn Buse, PhD: Where Are Patients With Migraine Seeking Care?


The clinical professor of neurology at Albert Einstein College of Medicine spoke about the trends revealed by the OVERCOME study, and how this data can be used to improve the management of the millions of patients with migraine in the US.

“There are a lot of people who can have their care needs met very well in primary care, including lifestyle and educational initiatives, acute treatments and preventive treatments. Those can all be covered for a large percentage of people with migraine very well in primary care. Considering that we have 40 million Americans with migraine, we really do need a large health care force to care for them.”

At the 2019 American Headache Society (AHS) Annual Meeting, July 11-14, 2019, in Philadelphia, Pennsylvania, Dawn Buse, PhD, clinical professor of neurology, Albert Einstein College of Medicine, and assistant professor, Ferkauf Graduate School of Psychology, Yeshiva University, presented data from the OVERCOME study in migraine.

The study explored the trends in the treatment of patients with migraine across the United States, and ultimately identified a number of interesting bits of information regarding how and where these individuals are receiving care and utilizing medications. One notable finding was that roughly 45% of patients with migraine sought care from their primary care physician—which is where the “overwhelming majority” of people will start seeking care according to Buse.

To find more about the findings of the OVERCOME study, Buse sat with NeurologyLive® to share her insight into these trends about where patients are seeking care and how it can be altered to improve the management of these patients.

For more coverage of AHS 2019, click here.


Buse D. Migraine Care Across the Healthcare Landscape in the United States Among Those with ≥4 Migraine Headache Days Per Month: Results of the OVERCOME Study. Presented at: 2019 American Headache Society Annual Meeting; July 11-14, 2019; Philadelphia, PA. Poster P60.

Related Videos
Svetlana Blitshteyn, MD, FAAN, director and founder of Dysautonomia Clinic
Anton P. Porsteinsson, MD
Lidia Maria Veras Rocha Moura, MD, PhD, MPH, FAAN
Tarun Singhal, MD, MBBS
Jessica Ailani, MD
© 2024 MJH Life Sciences

All rights reserved.